CYP cynata therapeutics limited

Mesoblast and Novartis collaboration, page-2

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Given the projected NPAT from Covid ARDs by the zealots of $1B NPAT by 2021, Rem-L is gone for just US$25m upfront (as $25m was equity according to ann).

    All the other "big numbers" like $500m have no detail. CYP has GvHD at $100m alone...

    So the Osiris landfill has been partnered....for peanuts of market cap, and costs to date.
    and how much of this goes to Osiris tech owners? No detail as usual.
    The rest of Rem-L is 50/50% basis.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
18.5¢
Change
0.000(0.00%)
Mkt cap ! $41.80M
Open High Low Value Volume
19.0¢ 19.0¢ 17.5¢ $23.71K 131.7K

Buyers (Bids)

No. Vol. Price($)
1 12500 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 86246 2
View Market Depth
Last trade - 16.10pm 21/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.